TWO NEW ITALIAN CANCER CENTERS SELECT ADVANCED RADIATION TREATMENT TECHNOLOGY FROM ELEKTA

TWO NEW ITALIAN CANCER CENTERS SELECT ADVANCED RADIATION TREATMENT TECHNOLOGY
FROM ELEKTA

PRESS RELEASE	
Stockholm, Sweden, September 25, 2007

Elekta has been selected by two progressive Italian hospitals opening up new
radiation therapy clinics, to supply advanced and clinically proven cancer
treatment systems for intensity modulated and image guided radiation therapy
(IMRT & IGRT). The two clinics will play an important role in their respective
region to provide first class radiation therapy and to increase cancer treatment
capacity.

S. Maria Annunziata Hospital, Florence and IRST Cancer Institute in Meldola,
Forlì, will both open up new radiation therapy departments, and have chosen
Elekta Synergy®, the leading system for advanced IMRT and 3D image guided
radiation therapy. The orders combined are valued at over EUR 8 M and the
systems will be installed in the autumn and winter 2007-08.

Elekta Synergy is an advanced digital linear accelerator integrating a suite of
advanced imaging tools with a digital linear accelerator to allow 3D imaging at
the time of treatment, providing clinicians with an unprecedented ability to
accurately define and treat tumors.

This innovative radiation therapy treatment system directly addresses the two
most persistent and significant problems in modern radiation therapy: internal
organ motion and errors in patient set-up. The result is unmatched clinical
confidence and enabling more aggressive treatment of tumors while minimizing
damage to surrounding healthy tissue. Today, in routine clinical use at hundreds
of centers around the world, Elekta Synergy provides clinicians with an
unprecedented ability to accurately define and treat tumors. 

S. Maria Annunziata Hospital

S. Maria Annunziata Hospital, is equipping it's new radiation therapy department
with  one Elekta Synergy system and one Elekta Synergy platform. When up and
running the radiation cancer clinic will work in close collaboration with the
radiation therapy department at Area Vasta Fiorentina, together creating a
comprehensive cancer treatment network benefiting all citizens of Florence. 

IRST Cancer Institute 

Opened in 2004, the IRST Cancer Institute located in Meldola, Forlì in the
Emilia Romagna region is a relative new cancer clinic, with a strong research
focus, with Elekta Synergy installed, the IRST Cancer Institute will be part of
a cancer care network that links several regional hospitals performing and
studying advanced cancer treatment technologies. 

At IRST Cancer Institute, Elekta will also install the MOSAIQ™ electronical
medical records (EMR) system and several advanced solutions for high precision
patient positioning and fixation, including HexaPOD™ for robotic corrections of
the patients' position in 6 degrees of freedom.

“Elekta is the leading provider of radiation therapy solutions in Italy. These
assignments to equip two brand new departments with technology and software
systems for image guided radiation therapy is further proof of the trust put in
us by the Italian radiation therapy community. Just like their colleagues in
other parts of the world, clinicians in Italy have been impressed by the options
offered by Elekta Synergy and the interest for this unique technology is very
strong. We are proud to partner with S. Maria Annunziata and IRST Cancer
Institute in the quest to improve cancer care in Italy”, said Massimo Abbiati,
Elekta's Business Unit Manager in Italy. 


******




For further information, please contact:

Peter Ejemyr, Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com  

About Elekta

Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for improved
cancer care and management of brain disorders. All of Elekta's solutions employ
non-invasive or minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. 

Clinical solutions include among others Leksell Gamma Knife® for non-invasive
treatment of brain disorders and Elekta Synergy® for image guided radiation
therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April
2005, the Elekta Group is the world's largest supplier of oncology software. 

Elekta's systems and solutions are used at over 4,500 hospitals around the world
to treat cancer and manage clinical operations as well as to diagnose and treat
brain disorders, including tumors, vascular malformations and functional
disorders. 

With approx. 2,000 employees, Elekta's corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com.